Cost-effectiveness plane (NHS costs and benefits discounted at 3.5%).

<p>Cost-effectiveness plane (NHS costs and benefits discounted at 3.5%).</p

Effect of cellulitis on quality of life.

<p>*Baseline trial visits: t₀ = screening visit, t₁ = trial visit at day 10.</p>+<p>Patient with no infection at t_0.</p>#<p>Patient with infection at t_0.</p

Resource use, cost and outcome in the combined PATCH trials.

<p>*Δ: Antibiotic – Placebo.</p>+<p>2010 costs; r_c refers to the discount rates applied to costs distributed over time.</p

Analysis of recurrence rates in the PATCH trials, exploring on-prophylaxis, post-prophylaxis and overall rates.

<p>Analysis of recurrence rates in the PATCH trials, exploring on-prophylaxis, post-prophylaxis and overall rates.</p

Sensitivity Analyses exploring influence of cost outliers and individual trials, NHS and Societal costs and benefits discounted at 3.5%.

<p>Sensitivity Analyses exploring influence of cost outliers and individual trials, NHS and Societal costs and benefits discounted at 3.5%.</p

Cost-effectiveness acceptability curves (CEACs), NHS and Societal costs and benefits discounted at 3.5%.

<p>Cost-effectiveness acceptability curves (CEACs), NHS and Societal costs and benefits discounted at 3.5%.</p